Synthetic Approaches to Biologically Active C-2-Substituted Benzothiazoles.

benzothiazole biological activity reactivity synthesis

Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
18 Apr 2022
Historique:
received: 14 03 2022
revised: 01 04 2022
accepted: 12 04 2022
entrez: 23 4 2022
pubmed: 24 4 2022
medline: 27 4 2022
Statut: epublish

Résumé

Numerous benzothiazole derivatives are used in organic synthesis, in various industrial and consumer products, and in drugs, with a wide spectrum of biological activity. As the properties of the benzothiazole moiety are strongly affected by the nature and position of substitutions, in this review, covering the literature from 2016, we focus on C-2-substituted benzothiazoles, including the methods of their synthesis, structural modification, reaction mechanisms, and possible pharmacological activity. The synthetic approaches to these heterocycles include both traditional multistep reactions and one-pot atom economy processes using green chemistry principles and easily available reagents. Special attention is paid to the methods of the thiazole ring closure and chemical modification by the introduction of pharmacophore groups.

Identifiants

pubmed: 35458794
pii: molecules27082598
doi: 10.3390/molecules27082598
pmc: PMC9027766
pii:
doi:

Substances chimiques

Benzothiazoles 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Molecules. 2019 Jan 04;24(1):
pubmed: 30621218
Org Lett. 2019 Oct 4;21(19):7863-7867
pubmed: 31525060
Mol Divers. 2018 Aug;22(3):723-741
pubmed: 29667008
Mini Rev Med Chem. 2021;21(3):314-335
pubmed: 32819243
Environ Sci Technol. 2018 May 1;52(9):5007-5026
pubmed: 29578695
Bioorg Med Chem Lett. 2016 Jan 1;26(1):43-5
pubmed: 26615887
Anticancer Agents Med Chem. 2016;16(6):722-39
pubmed: 26443027
Org Lett. 2018 May 18;20(10):3144-3147
pubmed: 29745678
Eur J Med Chem. 2016 Nov 29;124:763-772
pubmed: 27639367
Eur J Med Chem. 2018 Jan 1;143:283-291
pubmed: 29197733
Bioorg Med Chem Lett. 2016 Jan 1;26(1):213-7
pubmed: 26590102
ACS Omega. 2018 Dec 12;3(12):17135-17144
pubmed: 31458334
J Hazard Mater. 2018 Jan 15;342:10-19
pubmed: 28822245
Molecules. 2021 Apr 10;26(8):
pubmed: 33920281
Eur J Med Chem. 2017 Aug 18;136:468-479
pubmed: 28525845
Org Lett. 2017 Sep 1;19(17):4576-4579
pubmed: 28817291
Arch Pharm (Weinheim). 2019 Jan;352(1):e1800170
pubmed: 30488989
J Org Chem. 2021 Oct 15;86(20):13911-13923
pubmed: 34398612
Chem Heterocycl Compd (N Y). 2021;57(4):369-373
pubmed: 33994555
Bioorg Chem. 2018 Apr;77:6-15
pubmed: 29316509
Bioorg Med Chem. 2020 Jan 1;28(1):115187
pubmed: 31761725
Anticancer Agents Med Chem. 2017;17(1):57-66
pubmed: 27141878
Mini Rev Med Chem. 2020;20(1):12-23
pubmed: 31288719
Chem Soc Rev. 2017 Dec 7;46(23):7105-7123
pubmed: 29019488
Eur J Med Chem. 2016 Oct 4;121:318-330
pubmed: 27267002
Chem Commun (Camb). 2017 Oct 31;53(87):11917-11920
pubmed: 29044251
Comput Biol Chem. 2019 Feb;78:330-337
pubmed: 30639681
ACS Omega. 2017 Oct 31;2(10):7219-7229
pubmed: 30023542
Inorg Chem. 2016 Aug 15;55(16):7852-8
pubmed: 27082125
Bioorg Chem. 2020 Jan;95:103537
pubmed: 31884142
Bioorg Chem. 2017 Oct;74:82-90
pubmed: 28772160
Org Lett. 2019 Jan 18;21(2):469-472
pubmed: 30588818
Org Lett. 2019 Oct 4;21(19):7851-7856
pubmed: 31524412
Medchemcomm. 2017 Mar 7;8(5):924-941
pubmed: 30108808
Bioorg Chem. 2016 Feb;64:21-8
pubmed: 26637945
ACS Omega. 2019 Jan 07;4(1):368-373
pubmed: 31459336
Org Biomol Chem. 2018 Feb 21;16(8):1337-1342
pubmed: 29393937
J Org Chem. 2019 Oct 4;84(19):12596-12605
pubmed: 31502839
Bioorg Chem. 2018 Dec;81:630-641
pubmed: 30253336
Bioorg Med Chem Lett. 2016 Sep 15;26(18):4527-4535
pubmed: 27515320
Chemistry. 2018 Nov 7;24(62):16670-16676
pubmed: 30152561
Cancer Rep (Hoboken). 2019 Aug;2(4):e1155
pubmed: 32721126
J Org Chem. 2016 Apr 15;81(8):3149-60
pubmed: 26999637
J Med Chem. 2017 Feb 9;60(3):957-971
pubmed: 27992217
Org Biomol Chem. 2019 Dec 7;17(45):9743-9756
pubmed: 31696198
J Enzyme Inhib Med Chem. 2018 Dec;33(1):405-415
pubmed: 29372659
J Org Chem. 2021 Nov 5;86(21):14485-14492
pubmed: 34661400
Front Chem. 2017 Oct 31;5:88
pubmed: 29164104
J Oleo Sci. 2018;67(10):1209-1217
pubmed: 30305553
Chem Sci. 2020 Jul 9;11(30):7789-7799
pubmed: 34094152

Auteurs

Bagrat A Shainyan (BA)

A.E. Favorsky Irkutsk Institute of Chemistry, Siberian Branch of the Russian Academy of Sciences, 1 Favorsky Street, 664033 Irkutsk, Russia.

Larisa V Zhilitskaya (LV)

A.E. Favorsky Irkutsk Institute of Chemistry, Siberian Branch of the Russian Academy of Sciences, 1 Favorsky Street, 664033 Irkutsk, Russia.

Nina O Yarosh (NO)

A.E. Favorsky Irkutsk Institute of Chemistry, Siberian Branch of the Russian Academy of Sciences, 1 Favorsky Street, 664033 Irkutsk, Russia.

Articles similaires

Benzothiazoles Neurons Animals Cell Nucleolus Humans

Autophagy and inflammasome activation are associated with poor response to FLT3 inhibitors in patients with FLT3-ITD acute myeloid leukemia.

Brunno Gilberto Santos de Macedo, Manuela Albuquerque de Melo, Diego Antonio Pereira-Martins et al.
1.00
fms-Like Tyrosine Kinase 3 Humans Leukemia, Myeloid, Acute Autophagy Inflammasomes

Ahtziri S Carranza-Aranda, Luis Felipe Jave-Suárez, Flor Y Flores-Hernández et al.
1.00
Humans fms-Like Tyrosine Kinase 3 Leukemia, Myeloid, Acute Protein Kinase Inhibitors Cell Line, Tumor
Plant Diseases Real-Time Polymerase Chain Reaction Triticum Diamines Enzyme-Linked Immunosorbent Assay

Classifications MeSH